{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:25:38Z","timestamp":1792099538189,"version":"4.4.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Safely increasing organ utilization is a global priority. Donor serum transaminase levels are often used to decline livers, despite minimal evidence to support such decisions. This study aimed to investigate the impact of donor \u201cliver blood tests\u201d on transplant outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>This retrospective cohort study used the National Health Service registry on adult liver transplantation (2016\u20132019); adjusted regressions models were used to assess the effect of donor \u201cliver blood tests\u201d on outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>A total of 3299 adult liver transplant recipients were included (2530 following brain stem death, 769 following circulatory death). Peak alanine transaminase (ALT) ranged from 6 to 5927 U\/L (median\u2009=\u200945). Donor cause of death significantly predicted donor ALT; 4.2-fold increase in peak ALT with hypoxic brain injury versus intracranial hemorrhage (adjusted <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009&lt;\u20090.001). On multivariable analysis, adjusting for a wide range of factors, transaminase level (ALT or aspartate aminotransferase) failed to predict graft survival, primary nonfunction, 90-d graft loss, or mortality. This held true in all examined subgroups, that is, steatotic grafts, donation following circulatory death, hypoxic brain injury donors, and donors, in which ALT was still rising at the time of retrieval. Even grafts from donors with extremely deranged ALT (&gt;1000 U\/L) displayed excellent posttransplant outcomes. In contrast, donor peak alkaline phosphatase was a significant predictor of graft loss (adjusted hazard ratio\u2009=\u20091.808; 1.016-3.216; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.044).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Donor transaminases do not predict posttransplant outcomes. When other factors are favorable, livers from donors with raised transaminases can be accepted and transplanted with confidence. Such knowledge should improve organ utilization decision-making and prevent future unnecessary organ discard. This provides a safe, simple, and immediate option to expand the donor pool.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000004610","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T04:02:08Z","timestamp":1681790528000},"page":"2533-2544","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Donor Liver Blood Tests and Liver Transplant Outcomes: UK Registry Cohort Study"],"prefix":"10.1097","volume":"107","author":[{"given":"Samuel J.","family":"Tingle","sequence":"first","affiliation":[{"name":"National Institute for Health Research Blood and Transplant Research Unit (NIHR BTRU) in Organ Donation and Transplantation, Institute of Transplantation, Freeman Hospital, Newcastle upon Tyne, United Kingdom."},{"name":"Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Bramley","sequence":"additional","affiliation":[{"name":"National Institute for Health Research Blood and Transplant Research Unit (NIHR BTRU) in Organ Donation and Transplantation, Institute of Transplantation, Freeman Hospital, Newcastle upon Tyne, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Goodfellow","sequence":"additional","affiliation":[{"name":"National Institute for Health Research Blood and Transplant Research Unit (NIHR BTRU) in Organ Donation and Transplantation, Institute of Transplantation, Freeman Hospital, Newcastle upon Tyne, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily R.","family":"Thompson","sequence":"additional","affiliation":[{"name":"National Institute for Health Research Blood and Transplant Research Unit (NIHR BTRU) in Organ Donation and Transplantation, Institute of Transplantation, Freeman Hospital, Newcastle upon Tyne, United Kingdom."},{"name":"Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"McPherson","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Freeman Hospital, Newcastle upon Tyne, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve A.","family":"White","sequence":"additional","affiliation":[{"name":"National Institute for Health Research Blood and Transplant Research Unit (NIHR BTRU) in Organ Donation and Transplantation, Institute of Transplantation, Freeman Hospital, Newcastle upon Tyne, United Kingdom."},{"name":"Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin H.","family":"Wilson","sequence":"additional","affiliation":[{"name":"National Institute for Health Research Blood and Transplant Research Unit (NIHR BTRU) in Organ Donation and Transplantation, Institute of Transplantation, Freeman Hospital, Newcastle upon Tyne, United Kingdom."},{"name":"Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,4,18]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes.","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/hep.32272","article-title":"Effect of increased alcohol consumption during COVID-19 pandemic on alcohol-associated liver disease: a modeling study.","volume":"75","author":"Julien","year":"2022","journal-title":"Hepatology"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jhep.2021.08.012","article-title":"Epidemiology and risk-stratification of NAFLD-associated HCC.","volume":"75","author":"Ioannou","year":"2021","journal-title":"J Hepatol"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jhep.2019.08.025","article-title":"Epidemiology and surveillance for hepatocellular carcinoma: new trends.","volume":"72","author":"Singal","year":"2020","journal-title":"J Hepatol"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/tri.13744","article-title":"Organ utilization\u2014the next hurdle in transplantation?","volume":"33","author":"Neuberger","year":"2020","journal-title":"Transpl Int"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/ajt.15573","article-title":"Trends in deceased donor liver enzymes prior to transplant: the impact on graft selection and outcomes.","volume":"20","author":"Kaltenbach","year":"2020","journal-title":"Am J Transplant"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"10460","DOI":"10.3389\/ti.2022.10460","article-title":"Normothermic machine perfusion\u2014improving the supply of transplantable livers for high-risk recipients.","volume":"35","author":"Hann","year":"2022","journal-title":"Transpl Int"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jhep.2015.10.006","article-title":"EASL clinical practice guidelines: liver transplantation.","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cld.2016.12.004","article-title":"Extended criteria donors in liver transplantation.","volume":"21","author":"Vodkin","year":"2017","journal-title":"Clin Liver Dis"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7555\/JBR.32.20180087","article-title":"Hepatic ischemia-reperfusion injury in liver transplant setting: mechanisms and protective strategies.","volume":"33","author":"Rampes","year":"2019","journal-title":"J Biomed Res"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jhep.2018.12.033","article-title":"Survival advantage for patients accepting the offer of a circulatory death liver transplant.","volume":"70","author":"Taylor","year":"2019","journal-title":"J Hepatol"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"zrab019","DOI":"10.1093\/bjsopen\/zrab019","article-title":"Risk factors and impact of early anastomotic biliary complications after liver transplantation: UK registry analysis.","volume":"5","author":"Tingle","year":"2021","journal-title":"BJS Open"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2288-12-21","article-title":"Against quantiles: categorization of continuous variables in epidemiologic research, and its discontents.","volume":"12","author":"Bennette","year":"2012","journal-title":"BMC Med Res Methodol"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/sim.2331","article-title":"Dichotomizing continuous predictors in multiple regression: a bad idea.","volume":"25","author":"Royston","year":"2006","journal-title":"Stat Med"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1002\/sim.6986","article-title":"Quantifying the impact of different approaches for handling continuous predictors on the performance of a prognostic model.","volume":"35","author":"Collins","year":"2016","journal-title":"Stat Med"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/liv.12508","article-title":"Elevated alanine aminotransferase (ALT) in the deceased donor: impact on early post-transplant liver allograft function.","volume":"35","author":"Mangus","year":"2015","journal-title":"Liver Int"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/TP.0000000000003945","article-title":"Transplantation of extended criteria donor livers following continuous normothermic machine perfusion without recooling.","volume":"106","author":"Chen","year":"2022","journal-title":"Transplantation"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/SLA.0000000000005110","article-title":"Hypothermic oxygenated machine perfusion reduces early allograft injury and improves post-transplant outcomes in extended criteria donation liver transplantation from donation after brain death: results from a multicenter randomized controlled trial (HOPE ECD-DBD).","volume":"274","author":"Czigany","year":"2021","journal-title":"Ann Surg"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1111\/j.1600-6143.2012.04195.x","article-title":"The Eurotransplant donor risk index in liver transplantation: ET-DRI.","volume":"12","author":"Braat","year":"2012","journal-title":"Am J Transplant"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/TP.0000000000001576","article-title":"Factors associated with short- and long-term liver graft survival in the United Kingdom: development of a UK donor liver index.","volume":"101","author":"Collett","year":"2017","journal-title":"Transplantation"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1600-6143.2006.01242.x","article-title":"Characteristics associated with liver graft failure: the concept of a donor risk index [published correction appears in Am J Transplant. 2018;18(12):3085].","volume":"6","author":"Feng","year":"2006","journal-title":"Am J Transplant"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"9871","DOI":"10.1038\/s41598-018-27960-7","article-title":"A donor quality index for liver transplantation: development, internal and external validation [published correction appears in Sci Rep. 2018;8(1):15109].","volume":"8","author":"Winter","year":"2018","journal-title":"Sci Rep"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1097\/01.TP.0000158877.74629.AA","article-title":"Donor characteristics associated with liver graft survival.","volume":"79","author":"Cuende","year":"2005","journal-title":"Transplantation"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"e40140","DOI":"10.5812\/hepatmon.40140","article-title":"Transplantation of deceased donor livers with elevated levels of serum transaminases at Shiraz transplant center.","volume":"16","author":"Fakhar","year":"2016","journal-title":"Hepat Mon"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/j.1478-3231.2011.02525.x","article-title":"Liver transplantation using donor organs with markedly elevated liver enzymes: how far can we go?","volume":"31","author":"Radunz","year":"2011","journal-title":"Liver Int"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1111\/tri.13978","article-title":"The prognostic significance of serum aspartate transaminase and gamma-glutamyl transferase in liver deceased donors.","volume":"34","author":"Capelli","year":"2021","journal-title":"Transpl Int"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1136\/postgradmedj-2015-133715","article-title":"Evaluation of abnormal liver function tests.","volume":"92","author":"Agrawal","year":"2016","journal-title":"Postgrad Med J"},{"key":"R33-20250604","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1007\/BF01299887","article-title":"Serum alanine aminotransferase (ALT) elevation in asymptomatic US Air Force basic trainee blood donors.","volume":"38","author":"Kundrotas","year":"1993","journal-title":"Dig Dis Sci"},{"key":"R34-20250604","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1093\/clinchem\/46.12.2050","article-title":"Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring.","volume":"46","author":"Dufour","year":"2000","journal-title":"Clin Chem"},{"key":"R35-20250604","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2125.2007.03001.x","article-title":"Muscular exercise can cause highly pathological liver function tests in healthy men.","volume":"65","author":"Pettersson","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"R36-20250604","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/TP.0000000000003573","article-title":"Design, analysis, and pitfalls of clinical trials using ex situ liver machine perfusion: the international liver transplantation society consensus guidelines.","volume":"105","author":"Martins","year":"2021","journal-title":"Transplantation"},{"key":"R37-20250604","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.ajpath.2018.03.008","article-title":"Understanding liver regeneration: from mechanisms to regenerative medicine.","volume":"188","author":"Gilgenkrantz","year":"2018","journal-title":"Am J Pathol"},{"key":"R38-20250604","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/jcp.21172","article-title":"Liver regeneration.","volume":"213","author":"Michalopoulos","year":"2007","journal-title":"J Cell Physiol"},{"key":"R39-20250604","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/hep4.1816","article-title":"Is hepatocyte necrosis a good marker of donor liver viability during machine perfusion?","volume":"6","author":"Neil","year":"2022","journal-title":"Hepatol Commun"},{"key":"R40-20250604","doi-asserted-by":"crossref","first-page":"e14380","DOI":"10.1111\/ctr.14380","article-title":"Hepatocyte necrosis on liver allograft biopsy: normothermic machine perfusion is the ideal platform for using these grafts in high-risk recipients.","volume":"35","author":"Hann","year":"2021","journal-title":"Clin Transplant"},{"key":"R41-20250604","first-page":"15","article-title":"Clinical implications of hepatic progenitor cell activation in non-alcoholic fatty liver disease.","volume":"7","author":"Younes","year":"2021","journal-title":"Hepatoma Res"},{"key":"R42-20250604","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.jhep.2018.03.004","article-title":"Hepatic progenitors in liver regeneration.","volume":"69","author":"Raven","year":"2018","journal-title":"J Hepatol"},{"key":"R43-20250604","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature23015","article-title":"Cholangiocytes act as facultative liver stem cells during impaired hepatocyte regeneration [published correction appears in Nature. 2018;555(7696):402].","volume":"547","author":"Raven","year":"2017","journal-title":"Nature"},{"key":"R44-20250604","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/00004836-200608000-00015","article-title":"Nonalcoholic fatty liver disease presenting with an isolated elevated alkaline phosphatase.","volume":"40","author":"Pantsari","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"R45-20250604","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/cc4975","article-title":"Coagulation abnormalities in critically ill patients.","volume":"10","author":"Levi","year":"2006","journal-title":"Crit Care"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004610","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:01:26Z","timestamp":1749060086000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,18]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004610","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,18]]}}}